#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2220	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2589	192.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1596	1596	C	261	C,G	215,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3644	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4102	199.1	0	.	n	.	0	T695C	SNP	695	695	T	1393	1393	C	232	C	182	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3644	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4102	199.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	2035	2035	A	268	A	233	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3644	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4102	199.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2669	2669	C	236	C	207	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3644	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4102	199.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2743	2743	A	255	A,G	213,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3644	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4102	199.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3295	3295	C	252	C,A	214,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	224	folP	855	855	100.0	folP.l15.c4.ctg.1	1928	27.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1200	1202	AGC	40;40;39	A,G;G;C	34,1;35;34	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	660	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3959	39.1	1	SNP	p	S91F	1	.	.	271	273	TTC	922	924	TTC	44;44;44	T;T;C,A	36;38;38,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	660	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3959	39.1	1	SNP	p	D95G	1	.	.	283	285	GGC	934	936	GGC	44;44;45	G;G;C	38;38;39	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	660	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3959	39.1	1	SNP	p	G95N	0	.	.	283	285	GGC	934	936	GGC	44;44;45	G;G;C	38;38;39	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	214	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1500	33.0	1	SNP	p	G45D	1	.	.	133	135	GAC	490	492	GAC	49;49;49	G;A;C	39;37;40	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	174	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1057	31.4	0	.	n	.	0	A197.	DEL	197	197	A	643	643	A	64	A	57	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	956	958	AAC	43;43;43	A,C;A;C	26,1;31;37	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	1	SNP	p	S87I	0	.	.	259	261	AGT	959	961	AGT	43;43;44	A,C;G;T,G	36,1;38;35,3	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	1	SNP	p	S87W	0	.	.	259	261	AGT	959	961	AGT	43;43;44	A,C;G;T,G	36,1;38;35,3	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	1	SNP	p	S87R	0	.	.	259	261	AGT	959	961	AGT	43;43;44	A,C;G;T,G	36,1;38;35,3	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	1	SNP	p	S88P	0	.	.	262	264	TCC	962	964	TCC	44;44;44	T;C,T;C	36;37,2;38	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	0	HET	.	.	.	T1996C	.	1996	1996	T	2696	2696	T	38	T,C	26,6	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	667	590	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3533	39.1	0	HET	.	.	.	T1940G	.	1940	1940	T	2640	2640	T	46	T,G	35,7	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	536	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3260	38.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1879	1881	GGC	40;40;41	G;G;C	35;31;33	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1392	1394	GCA	59;56;56	G;C,A,G;A,C	49;43,1,1;47,2	penA.13.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1395	1397	ATC	56;56;56	A;T,C,A;C	46;47,1,1;49	penA.13.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1407	1409	GTG	54;54;54	G;T;G	46;44;47	penA.13.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1407	1409	GTG	54;54;54	G;T;G	46;44;47	penA.13.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1911	1913	ACC	36;36;36	A,C;C;C	20,1;27;28	penA.13.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1965	1967	GTG	31;31;32	G;T,G;G	22;21,2;23	penA.13.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1965	1967	GTG	31;31;32	G;T,G;G	22;21,2;23	penA.13.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2088	2090	GGC	24;24;24	G;G;C,T	22;22;21,1	penA.13.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2097	2099	GGC	23;23;23	G;G;C	20;18;16	penA.13.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	464	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2468	42.2	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2115	2117	TCG	22;22;22	T;C;G,C	12;16;20,1	penA.13.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	155	620	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3442	39.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1788	1790	CCG	41;41;41	C;C;G,C	27;30;24,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	155	620	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3442	39.8	0	HET	.	.	.	T1215G	.	1215	1215	T	1742	1742	T	46	T,G	29,5	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	300	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2168	32.0	0	.	p	.	0	A17T	NONSYN	49	51	GCA	499	501	ACA	23;23;23	A;C;A	20;19;20	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	300	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2168	32.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	514	516	GGC	28;28;28	G;G;C	23;23;23	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	300	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2168	32.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	696	696	C	18	C	13	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	718	720	GGA	69;69;69	G;G,A;A	56;55,1;58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	T87A	NONSYN	259	261	ACT	835	837	GCT	51;51;50	G;C;T,G	41;44;42,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	T89S	NONSYN	265	267	ACC	841	843	AGC	50;50;51	A;G;C	41;46;44	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1003	1005	CAA	54;54;54	C;A;A	48;48;48	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1027	1029	GCA	52;52;52	G;C;A	45;44;44	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1135	1137	CAA	56;56;55	C;A;A,C	48;48;46,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1141	1143	AGC	54;54;54	A,C;G;C	45,1;47;45	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1210	1210	T	52	T,G	43,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	1	SNP	p	G120K	1	.	.	358	360	AAG	934	936	AAG	50;50;48	A;A;G	44;43;43	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	1	SNP	p	A121D	1	.	.	361	363	GAC	937	939	GAC	49;47;47	G;A;C,A	44;43;42,1	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	388	porB1b	1041	1041	98.08	porB1b.l15.c4.ctg.1	2212	40.8	1	SNP	p	D121N	0	.	.	361	363	GAC	937	939	GAC	49;47;47	G;A;C,A	44;43;42,1	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1264	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5421	54.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2243	2245	AAT	67;66;66	A;A;T	59;58;57	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	136	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1747	18.3	1	SNP	p	V57M	1	.	.	169	171	ATG	860	862	ATG	45;45;45	A;T;G	40;41;41	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
